Product Images Dofetilide

This is a chart showing the changes in QTc intervals in correlation to the plasma concentration levels of Dofetilide on Day23 (Steady State). The chart displays the mean change from baseline QTc in milliseconds at different levels of Dofetilide plasma concentration. There is no further information available.*

Not available.*

This seems to be a partial description of a clinical trial with a drug called Dofetilide, administered in different doses (125, 250, and 500 meg BID), comparing its effectiveness with a placebo. The data shows results in terms of p-value according to the Log Rank test, plotted over 12 months. However, without additional context and information, it is not possible to provide a complete understanding of the study or its implications.*

This is a medical report that describes the results of a Log Rank Test. The p-values for 125 meg BID, 250 meg BID, and 500 meg BID are reported as 0.006, less than 0.001, and less than 0.001, respectively. The terms "Dofetilde" and "Dofetiide" are mentioned, which may refer to dosages or treatments of a medication. A time axis is provided with 6, 9, and 12 months marked.*

This text provides a set of instructions related to the administration of dofetilide medication in patients. It discusses the placement of a patient on telemetry and suggests the calculation of creatinine clearance to determine appropriate dosages of the medication. It also warns against contraindication in certain cases and emphasizes the monitoring of patient's QT or QTo levels post-dosage. A significant increase in QT or QTc levels may require a decrease in dosage or discontinuation of the medication.*

This is a product description of Dofetilide capsules that come in a pack of 60. Each capsule contains 0.125mg (25 mog) of Dofetilide. The recommended dosage is mentioned in the package insert, which should be checked before use. The capsules are child-resistant and should be stored at controlled room temperature. The manufacturer is Mayne Pharma, and the product is distributed by NorthStar Healthcare Holdings UC. For more information on the medication and its usage, the customers can refer to the provided medication guide or contact the pharmacist.*

This is a medication called Dofetiide in capsule form. Each capsule contains 250 micrograms (0.250 mg) of the medication. The recommended dosage is found in the package insert. The capsules should be stored at controlled room temperature and kept out of reach of children. The medication is manufactured by Mayne Pharma and medication guides are available at 1-800-206-7821.*

Each capsule of this medication contains 500mcg of Dofetilide. The package insert must be consulted for usual dosage. The capsules have a child-resistant closure and must be kept out of the reach of children. The medication guide is available by contacting the pharmacist at 1-800-206-7821. The medication should be stored at USP Controlled Room Temperature. It is manufactured by Mayne Pharma and distributed by NorthStar Healthcare Holdings.*